Cargando…
Plasma Angiotensin II Is Increased in Critical Coronavirus Disease 2019
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) employs angiotensin-converting enzyme 2 (ACE2) as its receptor for cell entrance, and studies have suggested that upon viral binding, ACE2 catalytic activity could be inhibited; therefore, impacting the regulation of the renin-angiotensin-...
Autores principales: | Camargo, Rafael L., Bombassaro, Bruna, Monfort-Pires, Milena, Mansour, Eli, Palma, Andre C., Ribeiro, Luciana C., Ulaf, Raisa G., Bernardes, Ana Flavia, Nunes, Thyago A., Agrela, Marcus V., Dertkigil, Rachel P., Dertkigil, Sergio S., Araujo, Eliana P., Nadruz, Wilson, Moretti, Maria Luiza, Velloso, Licio A., Sposito, Andrei C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263116/ https://www.ncbi.nlm.nih.gov/pubmed/35811697 http://dx.doi.org/10.3389/fcvm.2022.847809 |
Ejemplares similares
-
Safety and Outcomes Associated with the Pharmacological Inhibition of the Kinin–Kallikrein System in Severe COVID-19
por: Mansour, Eli, et al.
Publicado: (2021) -
Evaluation of the efficacy and safety of icatibant and C1 esterase/kallikrein inhibitor in severe COVID-19: study protocol for a three-armed randomized controlled trial
por: Mansour, Eli, et al.
Publicado: (2021) -
Contact and intrinsic coagulation pathways are activated and associated with adverse clinical outcomes in COVID-19
por: Henderson, Michael W., et al.
Publicado: (2022) -
Circulating Levels of Ang/Tie2 and VEGF-a Pathway Mediators Are Associated with Clinical Severity, Endothelial Barrier Disruption and Coagulation Activation in COVID-19
por: de Moraes, Carla Roberta Peachazepi, et al.
Publicado: (2021) -
Dietary fats promote functional and structural changes in the median eminence blood/spinal fluid interface—the protective role for BDNF
por: Ramalho, Albina F., et al.
Publicado: (2018)